Mission
Company Story
Why OOL was founded
After years inside gyn-onc drug development and commercialization, one gap kept surfacing: the people making strategic decisions rarely heard directly from the clinicians living those decisions. OOL was founded to close that gap — replacing filtered survey data with structured, candid conversation.
Founder
Henry Haringsma
Founder & Managing Partner
Two decades across gynecologic oncology drug development, commercialization, and medical affairs — with a network built on long-standing clinical relationships.
Gyn Onc Drug Development
KOL Engagement
Medical affairs
KOL engagement
Strategic Positioning
OOL operates at the intersection
01
Clinical practice
Programs are grounded in how gynecologic cancer care is actually delivered — across academic centers, community practices, and care teams.
02
Scientific innovation
Fluency in the evolving treatment landscape, from mechanism and trial design to what new data means at the point of care.
03
Commercial strategy
Insight is shaped into decisions — positioning, messaging, and planning that brand and medical teams can act on.